Swissmedic launched own GMDP Database

Recommendation
29/30 April 2025
Hamburg, Germany
Batch Manufacturing Documents: from Preparation to Operational Excellence
The Swiss health authority Swissmedic launched the SwissGMDP Database, similar to the European Medicine Agency's (EMA) EudraGMDP database. It lists the GMP and GDP certificates of all companies in Switzerland with a valid establishment licence issued by Swissmedic. The certificates in the SwissGMDP database include all authorised activities, i.e. unlike EudraGMDP, the GDP activities and Switzerland-specific GMP activities of Swiss companies will also be listed in the certificates. All companies, authorities and individuals can easily view a company's GMP/GDP status using the SwissGMDP database.
Furthermore, SwissGMDP enables a query of all establishment licence holders with a valid establishment license including their sites and licenced operations and will replace the previous table of establishment licence holders.
The SwissGMDP database offers:
- Public access for all users;
- Free-of-charge access to electronic GMP/GDP certificates;
- Access to GDP certificates of companies whose licence covers only GDP activities;
- Inclusion of Switzerland-specific activities;
- Creation of Excel lists based on specific search criteria or for all sites;
- Improvement of the exchange of information between regulatory authorities, industry and the public;
- Support in protecting the medicinal product and active substance distribution chain by making it easier to check legitimate players.
You can find further information on using the SwissGMDP database in the Guidance document.
Related GMP News
19.03.2025Root Cause Analysis: Again, problems discovered in GMP-Inspections
19.03.2025ICMRA publishes Hybrid Inspection Pilot Summary Report
19.03.2025From Burkholderia to Ethylene Glycol - a List of Deficiencies at a Manufacturer of OTC Products
19.03.2025Warning Letter - Deficiencies in the Control of Raw and Starting Materials
19.03.2025Inadequate Microbiological Testing of Nonsterile Products - FDA Warning Letter
19.02.2025MRA on GMP Inspections between Switzerland and Canada extended